Many diseases are hereditary; for example, Huntington's disease and cystic fibrosis. Other diseases influenced by genes, such as diabetes and cancer. Many advances make a viable solution to target such inherited infections at the subatomic level and in this sense offer the possibility of new viable treatments (McClean, 1999). The qualities of substantial cells (somatic cells) can be controlled to alter a disease in a person. If the characteristics of the germ cells were modified, a hereditary disease could also be avoided (McClean, 1999). Application of genetic engineering Debates about the quality of treatment require understanding some parts of the fundamental science. Genes include deoxyribonucleic acid also known as (DNA), and they repeat during cell division, transmitting the data they encode to ensure all ages of cells and life forms (Sade, n.d.). Genes become useful through a chain of biochemical events: DNA in the cell nucleus is transcribed, by base coordination, into ribonucleic acid (mRNA), which then leaves the cell nucleus, attaches to cytosomal ribosomes, and is converted into proteins by mixing its bases with amino acids. Controlling the amount of protein delivered is accomplished through various mechanisms, including the creation of repressor and activator proteins, which maintain the presence of various amounts of protein (Sade, n.d.). Say no to plagiarism. Get a tailor-made essay on "Why Violent Video Games Shouldn't Be Banned"? Get an Original Essay Hereditary DNA causes changes in both the structure and measurements of the proteins it ultimately creates (Sade, n.d.). In recent times, many strategies have been produced to recognize genes related to particular diseases. Since 1990, when the major agreements for quality treatment were approved, more than 100 new research agreements have been initiated for a range of diseases, including cancer, HIV contamination, cystic fibrosis (CF) and numerous others (Pike, 2000). Possible future treatments for diseases such as Duchenne and hemoglobin disorders such as sickle cell anemia and beta-thalassemia may be possible in the near future (Pike, 2000). Due to somatic cell treatments, the nature of a specific disease and several factors determine the specific cells focused for hereditary control. Target cells have included lung, liver, white blood, endothelial, and cancer cells (Pike, 2000). All examinations to date have included somatic cells and the strategies used to unrealistically spread the modified germ cells. In any case, it seems likely that we will eventually be able to modify the qualities of the germ cells, with the aim that whatever progression is made will be passed on to the subjects' offspring (Pike,2000). Treatment of the quality of somatic cells, target cells that can be modified either in vitro or after incorporation into the host or in vivo. In current treatments (which are all made up of cells), vectors are used to bring new hereditary material into target cells (Sade, n.d.). Vectors are operators to which new inherited material joins. Early studies addressing inequality used retroviral vectors (Yash, 2015). Retroviruses are RNA infections that enter cells and use the reverse transcriptase catalyst to transform RNA into DNA (reciprocal DNA or cDNA), thereby adding viral hereditary material to the host genome. Scientists can replace part of the viral RNA with human RNA that, in the host cell, deciphers the cDNA,).